Literature DB >> 3917619

Benefit-cost analysis of active surveillance of primary care physicians for hepatitis A.

M W Hinds, J W Skaggs, G H Bergeisen.   

Abstract

We identified two random samples of 216 primary care physicians each. In one sample, we made weekly telephone contact for active hepatitis A (HA) surveillance; in the other, we made no such contact (passive surveillance). Appropriate county health departments were notified whenever we identified a HA case by active surveillance. Active surveillance was associated with a 2.8-fold increase in reported HA cases compared to passive surveillance. The estimated benefit: cost ratio active/passive surveillance was 2.5:1.

Entities:  

Mesh:

Year:  1985        PMID: 3917619      PMCID: PMC1645977          DOI: 10.2105/ajph.75.2.176

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  9 in total

1.  The economic impact of viral hepatitis in the United States.

Authors:  D D Tolsma; J A Bryan
Journal:  Public Health Rep       Date:  1976 Jul-Aug       Impact factor: 2.792

2.  The reporting of communicable diseases.

Authors:  R Marier
Journal:  Am J Epidemiol       Date:  1977-06       Impact factor: 4.897

3.  The protective efficacy of immune serum globulin in hepatitis A: a statistical approach.

Authors:  P J Landrigan; D H Huber; G D Murphy; W B Creech; J A Bryan
Journal:  JAMA       Date:  1973-01-01       Impact factor: 56.272

4.  The surveillance of infectious diseases.

Authors:  S B Thacker; K Choi; P S Brachman
Journal:  JAMA       Date:  1983-03-04       Impact factor: 56.272

5.  Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont.

Authors:  R L Vogt; D LaRue; D N Klaucke; D A Jillson
Journal:  Am J Public Health       Date:  1983-07       Impact factor: 9.308

6.  Male urethritis in King County, Washington, 1974-75: I. Incidence.

Authors:  J L Gale; M W Hinds
Journal:  Am J Public Health       Date:  1978-01       Impact factor: 9.308

7.  Viral hepatitis in Israel: the effect of canvassing physicians on notifications and the apparent epidemiological pattern.

Authors:  D Brachott; J W Mosley
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

8.  Assessment of immunoglobulin use for hepatitis A control in New Mexico.

Authors:  J M Mann; D P Francis; R E Hoffman; J Montes
Journal:  Public Health Rep       Date:  1982 Nov-Dec       Impact factor: 2.792

9.  Surveillance and control of infectious diseases: progress toward the 1990 objectives.

Authors:  W R Dowdle
Journal:  Public Health Rep       Date:  1983 May-Jun       Impact factor: 2.792

  9 in total
  3 in total

1.  Evaluation of a national surveillance unit.

Authors:  M Gazarian; K Williams; E Elliott; K Chant; H Longbottom; C Mellis; T Nolan; R K Oates; A Ruben
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

2.  Estimating the cost to U.S. health departments to conduct HIV surveillance.

Authors:  Ram K Shrestha; Stephanie L Sansom; Benjamin T Laffoon; Paul G Farnham; R Luke Shouse; Karen MacMaster; H Irene Hall
Journal:  Public Health Rep       Date:  2014 Nov-Dec       Impact factor: 2.792

Review 3.  Economic Evaluations of Public Health Surveillance Systems: a Systematic Review.

Authors:  Magid Herida; Benoit Dervaux; Jean-Claude Desenclos
Journal:  Eur J Public Health       Date:  2016-02-05       Impact factor: 3.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.